Answers are grounded in this paper and cite their sources.
Papillary thyroid carcinoma (PCT), follicular origin are divided into RAS-like malignancies and BRAF-like malignancies according to their molecular characteristics and aggressiveness. With the continuous development of the molecular level, genetic mutations are significant in the diagnosis, treatment and prognosis of papillary thyroid carcinoma. This paper discusses the latest progress of papillary thyroid cancer gene mutation and its clinical application, in order to provide more efficient diagnosis and treatment means for patients.
No takes yet. Share an insight, caveat, or question.
Xing et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: